Dr. Nardi is a staff pathologist at the Massachusetts General Hospital. Her current clinical work includes implementing molecular assays for hematological malignancies at the Center for Integrated Diagnostics (CID).



Centers & Specialties

Cancer Center

Clinical Interests
  • Hematopathology
  • Gastrointestinal (GI) pathology
Medical Education
  • MD, University of Genoa School of Medicine
  • Residency, Massachusetts General Hospital
  • Fellowship, Brigham and Women's Hospital|Fellowship, Massachusetts General Hospital|Fellowship, University of Genova
Board Certifications
  • Pathology
  • Hematology
  • Molecular Genetic Pathology
  • Boston: Massachusetts General Hospital
Insurances Accepted
  • Aetna Health Inc.
  • Beech Street
  • Blue Cross Blue Shield - Blue Care 65
  • Blue Cross Blue Shield - Indemnity
  • Blue Cross Blue Shield - Managed Care
  • Blue Cross Blue Shield - Partners Plus
  • Centene/Celticare
  • Cigna (PAL #'s)
  • Fallon Community HealthCare
  • Great-West Healthcare (formally One Health Plan)
  • Harvard Pilgrim Health Plan - ACD
  • Harvard Pilgrim Health Plan - PBO
  • Health Care Value Management (HCVM)
  • Humana/Choice Care PPO
  • Medicaid
  • Medicare
  • Medicare - ACD
  • Neighborhood Health Plan - ACD
  • Neighborhood Health Plan - PBO
  • OSW - New Hampshire
  • OSW - Rhode Island
  • Private Health Care Systems (PHCS)
  • Railroad Medicare
  • Railroad Medicare - ACD
  • Senior Whole Health
  • TriCare
  • Tufts Health Plan
  • Unicare
  • United Healthcare (non-HMO) - ACD
  • United Healthcare (non-HMO) - PBO
Patient Age Group

Edit Profile


Dr. Nardi is a staff pathologist with sign-out responsibilities for gastrointestinal pathology, hematopathology, and molecular genetic pathology. Methods include frozen section diagnosis, hematoxylin and eosin (H&E) stain, and immunohistochemical stains, flow cytometric analysis, and molecular techniques including PCR-based methods, FISH, array comparative genomic hybridization and next generation sequencing. She is currently setting up molecular assays for hematological malignancies at the Center for Integrated Diagnostics (CID). Dr. Nardi?s teaches and supervises residents and fellows in gastrointestinal pathology, hematopathology and molecular diagnostics. She is re-designing the resident's molecular diagnostics curriculum and rotation. She presents four to six didactic sessions per year based on problem-set discussions (so-called ?outs?) to pathology residents, fellows, visiting trainees and attending pathologists. She delivers two molecular diagnostic lectures to the cytopathology group per year, and three to four didactic lectures to trainees in Molecular Diagnostics rotation three to four times per year. Dr. Nardi oversees and actively presents at weekly educational conferences (the ?CID Weekly?), which include journal club, didactics, in-depth discussion of interesting cases, and presentations by invited speakers for pathology  residents, fellows, technicians, and attending pathologists. Dr. Nardi is also an Instructor for the Immunology, Microbiology, and Pathology (IMP) course at Harvard Medical School.

Edit Profile

Research & Publications

Research Summary

Dr. Nardi?s research is focused on molecular characterization of rare solid tumors and of myeloid neoplasms, in an effort to uncover underlying genetic driver mutations amenable to therapeutic intervention or responsible for acquired resistance to therapy. Dr. Nardi's research interests include

  • Resistance to targeted therapeutics
  • Genetic alterations in hematological malignancies and solid tumors
  • Novel diagnostic and prognostic markers in hematological malignancies and solid tumors
  • Development and implementation of molecular assays

For more information about research concepts and co-authors visit  Dr. Nardi's profile at the Harvard Clinical and Translational Science Center.


View my most recent publications at PubMed

Edit Profile


Pathology Associates
55 Fruit Street
Boston MA, 02114-2696
Phone: 617-726-2971

Edit Profile